Wealth Awesome
TSX open
Loading markets…
Interactive Brokers: options trading made simple with the IBKR Options Wizard.

Insider · SEDI

Adam Rogers

Adam Rogers has reported about $52.1M in shares of NervGen Pharma Corp on SEDI, Canada's insider filing system. That is #183 among the insiders we track.

Holdings as of November 17, 2026 · 10% holder

Disclosed holdings

$52.1M

Companies

1

Buys / sells (12 months)

0 / 0

Net bought (12 months)

—

How to read insider buying

An insider buy is someone putting their own money where their mouth is, and insiders have the closest view of the business. Founders and CEOs buying their own company is common. The more telling pattern is an experienced investor holding stakes across several companies and adding over time: big buyers rarely stop at one purchase, so the first filings can put you early.

The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.

Holdings by company

Latest balance reported on SEDI for each company (direct and through holding companies), valued at the latest close.

CompanyRoleSharesValueLast filing
NervGen Pharma CorpNGEN.V · all insiders10% holder10,119,497$52.1M2026-06-30

Recent insider filings

DateCompanyTypeSharesPriceBalance after
2026-06-30NervGen Pharma CorpCommon SharesCompensation for services61,713$3.64119,497
2026-06-30NervGen Pharma CorpCommon SharesCompensation for services37,784$3.6457,784
2026-05-26NervGen Pharma CorpWarrants (Common Shares) · via PFP Biosciences Holdings LLCAcquisition or disposition…800,000$3.68—
2026-05-26NervGen Pharma CorpCommon Shares · via PFP Biosciences Holdings LLCAcquisition or disposition…800,000$2.50—
2026-05-13NervGen Pharma CorpOptions (Common Shares)Grant of options1,146,108$3.99—
2026-02-09NervGen Pharma CorpOptions (Common Shares)Grant of options103,092$5.57—
2026-02-09NervGen Pharma CorpOptions (Common Shares)Grant of options614,799$5.06—
2025-11-19NervGen Pharma CorpWarrants (Common Shares) · via Paul Fireman 2006 Revocable TrustCorrection of information-428,571—0
2025-11-19NervGen Pharma CorpWarrants (Common Shares) · via Paul Fireman 2006 Revocable TrustAcquisition or disposition…428,571$2.65—
2025-11-19NervGen Pharma CorpWarrants (Common Shares) · via Paul and Phyllis Fireman Charitable Foundation (PFP Foundation)Acquisition or disposition…476,190$2.65—
2025-11-19NervGen Pharma CorpWarrants (Common Shares) · via Paul and Phyllis Fireman Charitable Foundation (PFP Foundation)Correction of information-476,190—0
2025-11-19NervGen Pharma CorpCommon Shares · via Paul Fireman 2006 Revocable TrustCorrection of information-857,143—0
2025-11-19NervGen Pharma CorpCommon Shares · via Paul Fireman 2006 Revocable TrustAcquisition or disposition…857,143$2.10—
2025-11-19NervGen Pharma CorpCommon Shares · via Paul and Phyllis Fireman Charitable Foundation (PFP Foundation)Acquisition or disposition…952,381$2.10—
2025-11-19NervGen Pharma CorpCommon Shares · via Paul and Phyllis Fireman Charitable Foundation (PFP Foundation)Correction of information-952,381—0
2025-05-16NervGen Pharma CorpOptions (Common Shares)Grant of options50,000$4.00390,000
2025-05-16NervGen Pharma CorpOptions (Common Shares)Exercise of options-10,000$1.74340,000
2025-05-16NervGen Pharma CorpCommon SharesExercise of options10,000$1.7420,000
2024-06-05NervGen Pharma CorpOptions (Common Shares)Grant of options50,000$1.79350,000
2023-05-23NervGen Pharma CorpOptions (Common Shares)Grant of options50,000$1.61300,000
2023-02-22NervGen Pharma CorpOptions (Common Shares)Grant of options50,000$1.94250,000
2022-11-15NervGen Pharma CorpOptions (Common Shares)Grant of options50,000$1.74200,000
2022-07-15NervGen Pharma CorpOptions (Common Shares)Grant of options150,000$1.99150,000
2022-07-13NervGen Pharma CorpWarrants (Common Shares) · via Paul Fireman 2006 Revocable TrustOpening Balance-Initial SE…———
2022-07-13NervGen Pharma CorpWarrants (Common Shares) · via PFP Biosciences Holdings LLCOpening Balance-Initial SE…——5,000,000
2022-07-13NervGen Pharma CorpWarrants (Common Shares) · via Paul and Phyllis Fireman Charitable Foundation (PFP Foundation)Correction of information-1,439,574—0
2022-07-13NervGen Pharma CorpWarrants (Common Shares) · via Paul and Phyllis Fireman Charitable Foundation (PFP Foundation)Opening Balance-Initial SE…——1,439,574
2022-07-13NervGen Pharma CorpOptions (Common Shares)Opening Balance-Initial SE…———
2022-07-13NervGen Pharma CorpCommon Shares · via Paul Fireman 2006 Revocable TrustOpening Balance-Initial SE…———
2022-07-13NervGen Pharma CorpCommon SharesOpening Balance-Initial SE…——10,000
2022-07-13NervGen Pharma CorpCommon Shares · via PFP Biosciences Holdings LLCOpening Balance-Initial SE…——10,000,000
2022-07-13NervGen Pharma CorpCommon Shares · via Paul and Phyllis Fireman Charitable Foundation (PFP Foundation)Correction of information-2,879,149—0
2022-07-13NervGen Pharma CorpCommon Shares · via Paul and Phyllis Fireman Charitable Foundation (PFP Foundation)Opening Balance-Initial SE…——2,879,149
2022-07-13NervGen Pharma CorpCommon Shares · via Paul and Phyllis Fireman Charitable Foundation (PFP Foundation)Opening Balance-Initial SE…———

Free with a Wealth Awesome account

Keep analysing Adam Rogers, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.

How we count it: for each company we take the latest share balance Adam Rogers reported on SEDI for common-type shares (held directly or through holding companies) and value it at the latest close. Options, warrants and share units are left out, and so are balances with no filing in the last three years (insiders stop reporting when they leave the role). This is not a net worth figure: it covers only Canadian-listed shares reported on SEDI, and balances can lag until the next filing.

Canada's biggest insider shareholders · Latest insider trades

Awesome Portfolio™

Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →